Drugs / HS-20136-2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07483437 | May → Dec 2026 expected | — | Jiangsu Hansoh Pharmaceutical Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HS-20136-2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07483437 ↗ |
| Route | Subcutaneous | “Escalating doses of HS-20136-2 administered subcutaneously (SC) once in healthy participants.” NCT07483437 ↗ |